{
    "2018-04-05": [
        [
            {
                "time": "2018-03-06",
                "original_text": "J&J loses trial over claims linking cancer to asbestos in talc",
                "features": {
                    "keywords": [
                        "J&J",
                        "trial",
                        "cancer",
                        "asbestos",
                        "talc"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "J&J Ordered to Pay $37 Million Over Banker's Talc Cancer Claims",
                "features": {
                    "keywords": [
                        "J&J",
                        "pay",
                        "million",
                        "talc",
                        "cancer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "J&J Must Pay Millions Over Banker's Baby Powder Cancer Claim",
                "features": {
                    "keywords": [
                        "J&J",
                        "pay",
                        "millions",
                        "baby powder",
                        "cancer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "FDA Refuses Alkermes Depression Drug Review: 4 Stocks in Focus",
                "features": {
                    "keywords": [
                        "FDA",
                        "refuses",
                        "Alkermes",
                        "depression",
                        "drug"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Wall Street Brushes Off Trade War Fears: Top 5 Gainers",
                "features": {
                    "keywords": [
                        "Wall Street",
                        "trade war",
                        "gainers"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "5 Dividend Growth Stocks With Upside To Analyst Targets",
                "features": {
                    "keywords": [
                        "dividend growth",
                        "stocks",
                        "analyst targets"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "3 Emerging Technologies Set to Transform the Pharma World",
                "features": {
                    "keywords": [
                        "emerging technologies",
                        "pharma"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Johnson & Johnsonâ€™s Business Segments in 2017",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "business segments",
                        "2017"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-06",
                "original_text": "Alkermes' Bad News Could Be Good News for Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "bad news",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}